Observed Signal · Sep 24, 2026 · Product Launch · Source: t3n · Impact: 4/5 · Sentiment: Positive
Claude AI Agents Discover Novel CRISPR-Like Enzyme System ART
Anthropic's AI model Claude has discovered a novel enzyme system, named Array-Associated Reverse Transcriptases (ART), in bacteriophage genomes, which exhibits CRISPR-like properties. The discovery was made by approximately 950 AI agents over 21 hours, analyzing 1.9 billion protein clusters. The ART system comprises a reverse transcriptase, a partner gene, and repeated DNA segments. This marks Anthropic's first major finding from its new biotech lab, which operates a molecular biology facility in the Bay Area (BSL-1 and BSL-2). CEO Dario Amodei envisions AI curing severe diseases within five to ten years. However, experts have mixed reactions, with some praising the finding as exciting and others cautioning it may not rival CRISPR. The function of ART remains unclear, and Anthropic is seeking collaborations with scientists to further explore its potential.
Major AI model (Claude) demonstrates autonomous scientific discovery capability, which could reshape AI's role in research and drug development, with potential future impacts on AdTech via AI-driven innovation.
Track Google DeepMind Signals & Market Shifts in Real-Time
Polaris7 autonomous intelligence agents track regulatory filings, primary sources, executive changes, and deal flow 24/7. Create your free Explorer workspace to monitor these entities.
Key Takeaways & Evidence Grounding
- Anthropic's Claude AI discovered a novel CRISPR-like enzyme system called Array-Associated Reverse Transcriptases (ART).
- The discovery used approximately 950 AI agents in 21 hours, analyzing 1.9 billion protein clusters.
- ART consists of a reverse transcriptase enzyme, a partner gene, and repeated DNA segments.
- Anthropic operates a molecular biology lab in the Bay Area (BSL-1 and BSL-2).
- Anthropic acquired biotech startup Coefficient Bio for around $400 million to expand life sciences capabilities.
Connected Companies & Entities
3 Entities mapped“The company behind the discovery, operating the biotech lab and Claude AI....”
Ontology Mapping & Concepts
Related Market Signals & Shifts
Recent verified developments and strategic activity across this market segment.
Anthropic's Biology Lab Discovers Novel Enzyme System
Anthropic announced that its wet biology lab in the Bay Area, operational since spring 2026, has made a significant discovery: a novel enzyme system with properties reminiscent of CRISPR, found within bacteriophage DNA. The discovery was made 'mostly, though not entirely,' by Anthropic's AI model Claude, which used about 950 agents and consumed 210 million tokens over 21 hours. Anthropic CEO Dario Amodei acknowledged the prior work of others, including a similar system found by Stanford researchers. The lab currently performs experiments with human scientists at BSL-1 and BSL-2 levels, with no autonomous AI-controlled equipment yet. This announcement follows public statements from AI leaders about the need for safety testing, and highlights AI's growing role in biological research beyond Anthropic, including Stanford and UC San Francisco projects.
Google Rumored to Achieve Recursive Self-Improvement in AI
A cryptic tweet by leaker Lyra, featuring the acronym 'RSI' (Recursive Self-Improvement), has fueled speculation that Google DeepMind has achieved a major AI breakthrough. The rumor gained traction from reports of Sergey Brin's hands-on involvement, leadership changes at DeepMind, and rapid Gemini Flash model releases attributed to 'AI agent loops.' However, no concrete evidence—such as a model, paper, or benchmark—has been released, and Google's flagship Gemini 3.5 Pro remains unshiped, with its best model trailing rivals. Analysts point to AlphaEvolve's 23% improvement in a matrix multiplication kernel as the only tangible progress, but that falls far short of full RSI. The article concludes the claim remains unproven, and Google employees temper expectations, highlighting the gap between speculation and verified breakthroughs.
Richard Socher's Recursive Raises $4.65B Seed for Self-Improving AI
In a podcast episode, Richard Socher discusses his new venture, Recursive, which raised a $4.65B seed round to develop self-improving AI systems. Socher outlines his vision of a 'Eureka Machine' that can automate AI research itself, compressing years of human work into weeks. He details early results where Recursive's system outperformed humans and other agents on optimization tasks like NanoChat, NanoGPT, and NVIDIA GPU kernels. He critiques Anthropic's constitutional AI approach as ineffective and advocates for open-source models as geopolitical soft power. He also shares his framework of ten 'spaces of intelligence' and discusses the potential of AI for driving scientific breakthroughs in areas like energy, materials, and biology.
Track Real-Time Market Signals & Shifts
Set up custom watchlists to receive automated, evidence-grounded executive digests whenever material signals or shifts occur across your tracked landscape.